• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Abbott signs on to sponsor diabetes care equity effort

Abbott signs on to sponsor diabetes care equity effort

November 19, 2020 By Danielle Kirsh

AbbottAbbott and the American Diabetes Association this week announced that Abbott has become the first anchor sponsor of the Health Equity Now platform. The platform addresses health disparities for people living with diabetes.

The sponsorship includes a three-year, $5 million commitment to support the American Diabetes Association’s (ADA) advocacy and community-driven projects that are aimed at removing barriers to care and providing greater access to the latest medical technology and health resources for the underserved diabetes populations in the U.S.

“It’s important that people with diabetes in the U.S. have access to the latest innovations to effectively manage their condition and help them thrive,” ADA CEO Tracey Brown said in a news release. “It is time to tear down the systemic barriers that separate us based on zip code, income level, education, color and gender, and it’s time that we demand health equity now.”

According to the ADA, the risk of being diagnosed with diabetes is higher among Black Americans (77%), Latinos (66%) and Asian Americans (18%) when compared to white adults. The COVID-19 pandemic has brought more attention to health disparities in the U.S., with 50% of low-income Americans with diabetes having lost some or all income during the pandemic.

The ADA has created the Health Equity Bill of Rights to address the health inequities, which includes access to the latest medical advances. Abbott will support the organization’s advocacy to tear down the barriers that have limited access to high-quality medical technologies.

“No matter someone’s race, income level or background, quality care and life-changing technologies should be affordable and broadly accessible to all people living with diabetes,” Abbott’s senior VP of diabetes care Jared Watkin said. “Abbott is proud to support the ADA’s goal to work toward health equity and to advance access to the latest technologies for people with diabetes, helping them lead healthier, fuller lives with dignity.”

Through the partnership, Abbott will also drive sustained community engagement through local programs and initiatives to help improve diabetes-related health outcomes. The ADA will immediately begin to bring on experts and collaborate with underserved communities to develop program outreach models that include public health education, professional education and training, with other community services being rolled out next year.

Filed Under: Business/Financial News, Diabetes Tagged With: Abbott, American Diabetes Association

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy